Literature DB >> 16204906

Rome I criteria are more sensitive than Rome II for diagnosis of irritable bowel syndrome in Indian patients.

Rupa Banerjee1, Ong Wai Choung, Rajesh Gupta, Manu Tandan, Sandeep Lakhtakia, G V Rao, D Nageshwar Reddy.   

Abstract

AIM: To assess the utility and efficacy of Rome I and Rome II criteria for the diagnosis of irritable bowel syndrome (IBS) in India.
METHODS: Patients referred with a diagnosis of IBS by general practitioners answered a questionnaire about clinical features, including those listed in the Rome I and Rome II criteria. All patients underwent investigations to determine the cause of their symptoms. Sensitivity, positive predictive value and percent agreement of final diagnosis with Rome I and II criteria were calculated.
RESULTS: Among 138 patients studied, 6 patients had organic disease . Amongst 132 patients with functional bowel disease, Rome I criteria diagnosed more patients as IBS than Rome II criteria (110 [83.3%] vs. 41 [31.1%]); 36 patients fulfilled both the criteria. Of the patients positive by Rome I, 32.7% fulfilled Rome II criteria, and of those diagnosed by Rome II criteria, 87.8% fulfilled Rome I criteria. Seventeen patients did not fulfill either Rome I or Rome II criteria, and were classified as functional abdominal bloating, functional diarrhea or functional constipation.
CONCLUSION: Rome I criteria are more sensitive than Rome II criteria for the diagnosis of IBS in the Indian population.

Entities:  

Mesh:

Year:  2005        PMID: 16204906

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  7 in total

1.  Comparison of Manning, Rome I, II, and III, and Asian diagnostic criteria: report of the Multicentric Indian Irritable Bowel Syndrome (MIIBS) study.

Authors:  Uday C Ghoshal; Philip Abraham; Shobna J Bhatia; Sri Prakash Misra; Gourdas Choudhuri; K D Biswas; Karmabir Chakravartty; Sunil Dadhich; B D Goswami; V Jayanthi; Sunil Kumar; Abraham Koshy; K R Vinay Kumar; Govind Makharia; Sandeep Nijhawan; Nitesh Pratap; Gautam Ray; Sanjeev Sachdeva; Shivaram Prasad Singh; Varghese Thomas; Harsh Udawat
Journal:  Indian J Gastroenterol       Date:  2013-09-03

2.  Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy.

Authors:  Shunji Ishihara; Kazuo Yashima; Yoshinori Kushiyama; Akio Izumi; Kousaku Kawashima; Hirofumi Fujishiro; Haruhiko Kojo; Yoshinori Komazawa; Tetsuro Hamamoto; Tetsuo Yamamoto; Yuichiro Sasaki; Tatsunori Shimizu; Eiji Okamoto; Teiji Yoshimura; Koichiro Furuta; Naoya Noguchi; Hisao Tanaka; Yoshikazu Murawaki; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2012-03-30       Impact factor: 7.527

3.  Frequency of small intestinal bacterial overgrowth in patients with irritable bowel syndrome and chronic non-specific diarrhea.

Authors:  Uday C Ghoshal; Sunil Kumar; Mansi Mehrotra; Cp Lakshmi; Asha Misra
Journal:  J Neurogastroenterol Motil       Date:  2010-01-31       Impact factor: 4.924

4.  The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III.

Authors:  Dong Won Park; Oh Young Lee; Sung Gon Shim; Dae Won Jun; Kang Nyeong Lee; Hye Young Kim; Hang Lak Lee; Byung Chul Yoon; Ho Soon Choi
Journal:  J Neurogastroenterol Motil       Date:  2010-04-28       Impact factor: 4.924

5.  Irritable bowel syndrome aggregates strongly in families: a family-based case-control study.

Authors:  Y A Saito; J M Zimmerman; W S Harmsen; M De Andrade; G R Locke; G M Petersen; N J Talley
Journal:  Neurogastroenterol Motil       Date:  2008-07       Impact factor: 3.598

6.  Prevalence of irritable bowel syndrome: a community based study from northern India.

Authors:  Govind K Makharia; Anil K Verma; Ritvik Amarchand; Anil Goswami; Prashant Singh; Abhishek Agnihotri; Faizul Suhail; Anand Krishnan
Journal:  J Neurogastroenterol Motil       Date:  2011-01-26       Impact factor: 4.924

Review 7.  Epidemiological and clinical perspectives on irritable bowel syndrome in India, Bangladesh and Malaysia: A review.

Authors:  M Masudur Rahman; Sanjiv Mahadeva; Uday C Ghoshal
Journal:  World J Gastroenterol       Date:  2017-10-07       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.